Patents by Inventor Katrin Tertsch

Katrin Tertsch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION COMPRISING A GLP-1 AGONIST, AN INSULIN AND METHIONINE
    Publication number: 20220133890
    Abstract: A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof, an insulin or/and a pharmacologically tolerable salt thereof, and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin where appropriate.
    Type: Application
    Filed: July 2, 2021
    Publication date: May 5, 2022
    Inventors: Annika Hagendorf, Gerrit Hauck, Werner Mueller, Isabell Schoettle, Verena Siefke-Henzler, Katrin Tertsch
  • PHARMACEUTICAL COMPOSITION COMPRISING A GLP-1 AGONIST, AN INSULIN AND METHIONINE
    Publication number: 20200188516
    Abstract: A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof, an insulin or/and a pharmacologically tolerable salt thereof, and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin where appropriate.
    Type: Application
    Filed: October 28, 2019
    Publication date: June 18, 2020
    Inventors: Annika Hagendorf, Gerrit Hauck, Werner Mueller, Isabell Schoettle, Verena Siefke-Henzler, Katrin Tertsch
  • Pharmaceutical composition comprising a GLP-1 agonist, an insulin and methionine
    Patent number: 10029011
    Abstract: A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof, an insulin or/and a pharmacologically tolerable salt thereof, and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin where appropriate.
    Type: Grant
    Filed: November 11, 2010
    Date of Patent: July 24, 2018
    Assignee: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Annika Hagendorf, Gerrit Hauck, Werner Mueller, Isabell Schoettle, Verena Siefke-Henzler, Katrin Tertsch
  • Pharmaceutical Composition Comprising a GLP-1 Agonist, an Insulin and Methionine
    Publication number: 20180200370
    Abstract: A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof, an insulin or/and a pharmacologically tolerable salt thereof, and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin where appropriate.
    Type: Application
    Filed: November 3, 2017
    Publication date: July 19, 2018
    Inventors: Annika Hagendorf, Gerrit Hauck, Werner Mueller, Isabell Schoettle, Verena Siefke-Henzler, Katrin Tertsch
  • PHARMACEUTICAL COMPOSITION COMPRISING A GLP-1 AGONIST, AN INSULIN AND METHIONINE
    Publication number: 20120295846
    Abstract: A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof, an insulin or/and a pharmacologically tolerable salt thereof, and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin where appropriate.
    Type: Application
    Filed: November 11, 2010
    Publication date: November 22, 2012
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Annika Hagendorf, Gerrit Hauck, Werner Mueller, Isabell Schoettle, Verena Siefke-Henzler, Katrin Tertsch
  • LONG-ACTING FORMULATIONS OF INSULINS
    Publication number: 20120122774
    Abstract: The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
    Type: Application
    Filed: December 2, 2011
    Publication date: May 17, 2012
    Applicant: SANOFI
    Inventors: Reinhard Becker, Annke Frick, Peter Boderke, Christiane Fürst, Werner Müller, Katrin Tertsch, Ulrich Werner, Petra Loos, Isabell Schöttle
  • LONG-ACTING FORMULATIONS OF INSULINS
    Publication number: 20110301081
    Abstract: The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
    Type: Application
    Filed: May 18, 2011
    Publication date: December 8, 2011
    Applicant: SANOFI
    Inventors: Reinhard Becker, Annke Frick, Peter Boderke, Christiane Fürst, Werner Müller, Katrin Tertsch, Ulrich Werner, Petra Loos, Isabell Schöttle